Viking Therapeutics (VKTX) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 24.40 -1.43 (5.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.83 | 52 Week High | $5.17 | |||
| Open | $25.54 | 52 Week Low | $0.94 | |||
| Day High | $25.74 | P/E | N/A | |||
| Day Low | $24.36 | EPS | $0.00 | |||
| Volume | 4,669,339 | |||||
